An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Ironwood Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Ironwood Pharmaceuticals (Nasdaq: IRWD), a leader in gastrointestinal healthcare, announced that CEO Tom McCourt will present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 9:00 a.m. PT in San Francisco, CA. The live audio webcast can be accessed via the company's website, with a replay available for 14 days post-conference. Ironwood is renowned for its work on LINZESS®, a top medication for treating IBS-C and CIC. The company continues to innovate in GI treatments and aims to redefine care standards for patients.
Positive
None.
Negative
None.
BOSTON--(BUSINESS WIRE)--
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that Tom McCourt, CEO, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 9:00 a.m. Pacific Time / 12:00 p.m. Eastern Time at The Westin St. Francis in San Francisco, CA.
A live audio webcast of Ironwood’s presentation will be accessible through the Investors section of the company’s website at www.ironwoodpharma.com. To access the webcast, please log on to the Ironwood website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Ironwood’s website for 14 days following the conference.
About Ironwood Pharmaceuticals Ironwood Pharmaceuticals (Nasdaq: IRWD), an S&P SmallCap 600® company, is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). Under the guidance of our seasoned industry leaders, we continue to build upon our history of GI innovation and challenge what has been done before to shape what the future holds. We keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs.
Founded in 1998, Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts.
We routinely post information that may be important to investors on our website at www.ironwoodpharma.com. In addition, follow us on Twitter and on LinkedIn.
When will Ironwood Pharmaceuticals present at the J.P. Morgan Healthcare Conference?
Ironwood Pharmaceuticals will present at the J.P. Morgan Healthcare Conference on January 11, 2023, at 9:00 a.m. Pacific Time.
How can I access Ironwood's presentation during the healthcare conference?
You can access Ironwood's presentation via a live audio webcast on their website. It is recommended to log on about 15 minutes prior to the presentation.
What is Ironwood Pharmaceuticals known for?
Ironwood Pharmaceuticals is known for its work in gastrointestinal healthcare, specifically for its medication LINZESS®, which treats IBS-C and CIC.
Where is Ironwood Pharmaceuticals headquartered?
Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts.
Will there be a replay of Ironwood's presentation available?
Yes, a replay of Ironwood's presentation will be available on their website for 14 days after the conference.
